Gingival acquired lymphangiectasia as a long-term effect of post-oncology intervention: A 20-year institutional audit DOI
Pratibha Ramani,

Abilasha Ramasubramanian,

Suvarna Kizhakkoottu

et al.

Journal of Oral and Maxillofacial Pathology, Journal Year: 2024, Volume and Issue: 28(3), P. 428 - 433

Published: July 1, 2024

Gingiva is a keratinised mucosa akin to the skin and exposed in all modalities of treatment oral cancer. Acquired lymphangiectasia are acquired dilatations lymphatic channels secondary an external cause. They extremely rare cavity despite that cancers treated with different modalities.

Language: Английский

Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma DOI Creative Commons
D. V. Siva Sankar, Balachander Kannan, Vijayashree Priyadharsini Jayaseelan

et al.

Journal of Oral Biology and Craniofacial Research, Journal Year: 2023, Volume and Issue: 14(1), P. 1 - 7

Published: Dec. 3, 2023

A significant percentage of the world is distressed due to widespread and aggressive head neck squamous cell carcinoma (HNSCC). The prognosis for people with HNSCC remains grim, despite progress in treatment techniques. This underscores pressing demand discovery novel biomarkers enable early detection improve prognostic categorization.The present study aims identify expression PNMA1 gene clinicopathological characteristics, prognosis, association immune cells infiltration.The TCGA-HNSCC dataset first evaluated its relationship clinical aspects HNSCC. Following that, oral (OSCC), a primary type, used validate mRNA expression, via quantitative reverse transcription PCR (RT-qPCR). Kaplan-Meier plot was assess survival rates, Tumour Immune Estimation Resource (TIMER) database examine between significantly increased OSCC tumors. Significant correlations have been found characteristics HNSCC, such as tumor stage, grade, metastasis, HPV status patient survival. also correlated infiltration regulator genes.In conclusion, demonstrated that associated patient's prognosis. Hence, could serve biomarker promising therapeutic target

Language: Английский

Citations

5
Correlating the genetic alterations and expression profile of the TRA2B gene in HNSCC and LUSC DOI Creative Commons
Amba Esakki, Anitha Pandi,

Smiline Girija

et al.

Folia Medica, Journal Year: 2024, Volume and Issue: 66(5), P. 673 - 681

Published: Oct. 31, 2024

Transformer (TRA2B) is a serine/arginine-rich (SR)-like protein family that regulates the alternative splicing of several genes in concentration-dependent manner. Amplification TRA2B gene, which codes for TRA2B, occurs malignancies, including those lung, cervix, head and neck, ovary, stomach, uterine.

Language: Английский

Citations

1
Comment on, “T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant” DOI
Hethesh Chellapandian, Sivakamavalli Jeyachandran

Neurosurgical Review, Journal Year: 2024, Volume and Issue: 47(1)

Published: Oct. 8, 2024

Language: Английский

Citations

0
Gingival acquired lymphangiectasia as a long-term effect of post-oncology intervention: A 20-year institutional audit DOI
Pratibha Ramani,

Abilasha Ramasubramanian,

Suvarna Kizhakkoottu

et al.

Journal of Oral and Maxillofacial Pathology, Journal Year: 2024, Volume and Issue: 28(3), P. 428 - 433

Published: July 1, 2024

Gingiva is a keratinised mucosa akin to the skin and exposed in all modalities of treatment oral cancer. Acquired lymphangiectasia are acquired dilatations lymphatic channels secondary an external cause. They extremely rare cavity despite that cancers treated with different modalities.

Language: Английский

Citations

0